DANVERS, Mass., July 1, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, announced today that it has acquired ECP Entwicklungsgesellschaft mbH (“ECP”), a medical device company based in Berlin, Germany.
ECP is developing a product that is a percutaneous, expandable catheter pump which increases blood circulation from the heart with an external drive shaft. The pump design offers a potential flow rate of up to 4.5 liters/minute, and an insertion radius for the impeller and catheter of less than 10 French. ECP holds patents or patent applications in over 40 patent families, valid with expirations up to year 2033. These patents will be added to the approximately 100 patents and patent applications from the Impella® device.
Help employers find you! Check out all the jobs and post your resume.
